rs554073390
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM1PM2PM5PP3_Strong
The NM_000260.4(MYO7A):c.3502C>T(p.Arg1168Trp) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000199 in 1,556,494 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1168P) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000260.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYO7A | NM_000260.4 | c.3502C>T | p.Arg1168Trp | missense_variant, splice_region_variant | 27/49 | ENST00000409709.9 | NP_000251.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO7A | ENST00000409709.9 | c.3502C>T | p.Arg1168Trp | missense_variant, splice_region_variant | 27/49 | 1 | NM_000260.4 | ENSP00000386331 |
Frequencies
GnomAD3 genomes AF: 0.0000504 AC: 6AN: 118978Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000458 AC: 9AN: 196306Hom.: 0 AF XY: 0.0000654 AC XY: 7AN XY: 107108
GnomAD4 exome AF: 0.0000174 AC: 25AN: 1437418Hom.: 0 Cov.: 31 AF XY: 0.0000168 AC XY: 12AN XY: 713574
GnomAD4 genome AF: 0.0000504 AC: 6AN: 119076Hom.: 0 Cov.: 32 AF XY: 0.0000518 AC XY: 3AN XY: 57902
ClinVar
Submissions by phenotype
not provided Pathogenic:1Uncertain:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 24, 2024 | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 1168 of the MYO7A protein (p.Arg1168Trp). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individual(s) with clinical features of Usher syndrome and autosomal recessive deafness (PMID: 20052763, 21436283, 30303587, 33187236; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 553405). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. For these reasons, this variant has been classified as Pathogenic. - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2023 | MYO7A: PP3 - |
Hearing loss, autosomal recessive Pathogenic:1
Likely pathogenic, no assertion criteria provided | research | University of Washington Center for Mendelian Genomics, University of Washington | - | - - |
Autosomal dominant nonsyndromic hearing loss 11 Uncertain:1
Uncertain significance, criteria provided, single submitter | research | Baylor-Hopkins Center for Mendelian Genomics, Johns Hopkins University School of Medicine | - | - - |
Usher syndrome type 1;C1838701:Autosomal recessive nonsyndromic hearing loss 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | Aug 23, 2017 | - - |
MYO7A-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 28, 2023 | The MYO7A c.3502C>T variant is predicted to result in the amino acid substitution p.Arg1168Trp. This variant was reported in the heterozygous state without a second potentially causative variant in an individual with Usher syndrome (Le Guédard-Méreuze et al. 2010. PubMed ID: 20052763), and in the homozygous state in two siblings from a consanguineous family with nonsyndromic hearing loss (Doll et al. 2020. PubMed ID: 33187236). This variant occurs at the penultimate nucleotide of exon 27, although in vitro studies found no effect on splicing (Le Guédard-Méreuze et al. 2010. PubMed ID: 20052763). This variant is reported in 0.0085% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/11-76895759-C-T). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at